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Abstract
Following migration into the intestinal mucosa in inflammatory bowel disease
(IBD), neutrophils enter the intestinal lumen and are excreted. This provides
a basis for quantification of disease activity by measuring excreted label fol-
lowing injection of In-111-labeled neutrophils. In severe pan-colitis, 50% of
the injected In-111 is typically recovered in the feces, indicating that 50% of
neutrophil turnover is via fecal excretion. Neutrophils have an intravascular
lifespan of ~10 h and a distribution volume of ~10 L, so total body neutrophil
turnover is 10.N/10 cells/h, where N is the peripheral blood neutrophil count
(cells/L). Neutrophil loss via the colon in a patient with 50% fecal In-111 loss
is therefore N/120 cells/min. Pan-colonic mucosal-blood flow in pan-colitis is
200 mL/min, which would deliver N/5 neutrophils to the colon per min.
Therefore, 5/120, or 4%, of incoming neutrophils undergo migration into
inflamed bowel. If the 96% of nonmigrating cells exit in a primed state, then
at steady state >90% of circulating neutrophils would be primed if no depri-
ming took place. As the highest level of priming seen in IBD is ~40%, this
indicates that depriming within the circulation must take place. Using the
above values in the steady state equation relating priming rate to depriming
rate plus primed-cell destruction rate gives a mean depriming time of 35 min.
We conclude that a very small proportion of neutrophils entering a site of
inflammation migrate and that in vivo depriming must take place to limit the
numbers of primed neutrophils in the circulation.
Introduction
The molecular mechanisms underpinning the migration
of neutrophils from the blood into an inflammatory focus
have been extensively investigated, and include vascular
activation, neutrophil priming, neutrophil activation,
chemotaxis, and trans-endothelial migration (Ley et al.
2007). Against this background, however, the proportion
of neutrophils that enter an inflammatory focus from the
afferent blood supply is unknown. Neutrophil trafficking
in inflammatory bowel disease (IBD) provides an oppor-
tunity to address this issue because of previous work
using In-111-labeled neutrophils for imaging IBD and
quantifying disease activity from the percentage of admin-
istered activity that can be recovered in the feces, or lost
from the body (as determined by whole body counting).
Moreover, it is known from the imaging aspects of this
work that following migration into inflamed bowel, the
vast majority of neutrophils gain access to the intestinal
lumen and are excreted in the feces (Saverymuttu et al.
1982). In-111 proves an almost ideal radionuclide for
studying quantification of disease activity in IBD due to
its half-life, stability of intracellular binding (both in the
neutrophil and other cells, such as reticulo-endothelial
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macrophages, that subsequently ingest labeled neutrophils
(Peters et al. 1982)), and the absence of downstream
intestinal reabsorption of the label (as shown in gastro-
intestinal transit studies using orally administered In-111)
(Notghi 2006).
Disease activity in IBD was first quantified using
In-111-labeled neutrophils by measuring In-111 excretion
in a 4-day complete fecal collection following injection of
the labeled cells (Saverymuttu et al. 1983, 1985a). The
percentage of administered In-111 excreted in the feces in
normal subjects was essentially zero, but ranged from
10% in mild disease to >50% in severe and extensive
disease. Typical values in severe disease are 40–50%. The
evidence that all migrating cells access bowel lumen is
based on imaging, which shows that following the appear-
ance of substantial intestinal activity within the first few
hours after injection, the label then moves distally over
the subsequent hours and completely disappears from
bowel over about 4–5 days (Saverymuttu et al. 1982,
1983, 1985a, 1986; Carpani de Kaski et al. 1992). In-111-
labeled neutrophils migrating in severe bronchiectasis and
swallowed in sputum also clear from the lungs and bowel
within 5 days of injection (Currie et al. 1987).
Theory
Neutrophils are distributed throughout the body between
two pools: the circulating pool (= blood volume = 5 L)
and the marginating pool, which between them make up
the total blood neutrophil pool (Athens et al. 1961). It
has been shown from imaging that the marginating pool
is located predominantly within the liver, spleen, and
bone marrow (Saverymuttu et al. 1985b). Neutrophils
distribute about equally between the two pools so that
the total blood neutrophil pool is equivalent to 10 L.
Taking blood neutrophil count as N cells/L, the total
intravascular population is therefore 10.N.
Neutrophils, radiolabeled with P-32-diisopropyl fluoro-
phosphate (DFP-32) or In-111 are cleared from blood
exponentially with a half-time of ~7 h (Farahi et al. 2012;
Athens et al. 1961; Saverymuttu et al. 1985b). This corre-
sponds to a mean intravascular lifespan of 10 h, so intra-
vascular whole body neutrophil turnover can be taken to
be 10.N/10 cells/h = 10.N/600 cells/min = N/60 cells/min.
In severe pan-colitis with 50% of the administered
In-111-label lost into bowel lumen, neutrophil loss would
be N/120 cells/min.
Colonic perfusion has been measured in several experi-
mental settings, including nonanesthetized dogs, and is
variable. Values for total flow range from 35 to 133 mL/
min/100 g (Shoor et al. 1979; Bond et al. 1980; Ulrich-
Baker et al. 1986). Mucosal perfusion represents about
70% of total flow (Shoor et al. 1979). Measurements
exclusively of mucosal flow using the microsphere tech-
nique are consistent with this, with values ranging from
20–130 mL/min/100 g (Bond et al. 1980; Mortensen et al.
1991). Mucosal flow increases in the inflamed colon by
about 50% (Petersson et al. 2007). The empty colon
weighs about 500 g, so the best estimate for pan-colonic
mucosal flow in an inflamed colon is 200 mL/min, which
represents approximately 20% of splanchnic blood flow.
Therefore, neutrophil delivery to an inflamed colon in
a case of pan-colitis would be 0.2.N cells/min. So the
percentage of neutrophils arriving in the inflamed colon
on each pass that undergo migration is shown by:
% Migrating ¼ 100 ðN=120Þ
N=5
(1)
that is only 4%. If the inflamed colon had a mucosal flow
of 100 mL/min, the percentage of incoming neutrophils
undergoing migration would still be <10%.
Neutrophil half-life, based either on DFP-32 or In-111
labeling studies, has been shown not to be shortened in
inflammation (Athens et al. 1965; Saverymuttu et al.
1985b), but if it was, say 3.5 h instead of 7 h, then from
equation (1), it can be seen the percentage of cells
migrating would be ~8%. A recent study has suggested
neutrophil half-life may be much longer (Pillay et al.
2012), in which case the percentage migrating would
become even smaller. However, the relevant half-life is
that of the labeled cells.
If the large percentage (96% in the above example) of
neutrophils that entered colonic venous blood in IBD
were nevertheless all primed due to their passage through
an inflamed and cytokine-rich site, this might explain the
high levels of primed neutrophils found in the peripheral
blood of patients with severe inflammatory disease,
including IBD (Ussov et al. 1996). Knowing the percent-
age of afferent neutrophils that migrate allows us to
speculate on the extent of spontaneous neutrophil
depriming elsewhere in the circulation, the occurrence of
which is controversial, as follows.
At steady state, assuming 4% migration and that the
half-life of primed cells is, like unprimed cells, 7 h, then:
neutrophil priming rate ¼ neutrophil de-priming rate
þ primed neutrophil
destruction rate
(2)
Typically, 40% of circulating neutrophils are primed in
severe inflammation (Ussov et al. 1996), in which case we
can say there are 6 units of unprimed cells and 4 units of
primed cells per liter of circulating blood, giving totals of
30 units and 20 units, respectively. These totals will be
the same in the marginating pool, giving 40 units of
(2)
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primed cells in the total blood neutrophil pool; therefore
0:2 6 0:96 ¼ 40=t þ 40=600 cells/min (3)
where t is the mean time to deprime in vivo.
So t = 37 min.
Lower levels of circulating primed neutrophils would,
from equation (3), indicate faster rates of depriming; e.g.
t would be 13 min for 20% priming.
If there was no in vivo depriming then, in the above
scenario, the percentage of circulating primed cells would
(from eq. 3) be predicted to be >90%. Such high values
are not encountered. In vivo depriming must therefore
take place.
Discussion
This theoretical treatment suggests that the proportion of
neutrophils entering a site of inflammation that undergo
extravascular migration is surprisingly small (far <10%).
Such a small proportion provides the basis for the pres-
ence in peripheral blood of primed neutrophils in inflam-
matory disorders, including IBD, systemic vasculitis,
systemic sepsis, graft-versus-host disease, severe alcoholic
hepatitis and ARDS, if priming results, as assumed here,
from the exposure of neutrophils to pro-inflammatory
cytokines as they pass through a site of inflammation.
Arterio-venous gradients for neutrophil priming and neu-
trophil count have not, to our knowledge, been directly
measured across a site of inflammation.
Kitchen et al. (1996) demonstrated for the first time
spontaneous depriming of neutrophils in vitro, following
treatment with platelet activating factor. The halftime for
depriming was about 30 min, corresponding to a mean
depriming time of about 40 min, similar to t in the above
calculations. Some priming mediators, such as TNF-alpha
and GM-CSF, resulted in a far more prolonged priming
response, so the rate of in vivo depriming presumably
depends on which mediators neutrophils encounter as
they pass through the inflammatory focus. We have
assumed in equation (3) that all circulating primed neu-
trophils (Np) are reversibly primed. Depriming of revers-
ibly primed cells would be faster if Np consisted of both
reversibly and irreversibly primed neutrophils.
Primed neutrophils change shape and become less
deformable with the result that their transit time through
the lungs is prolonged (Downey et al. 1990). Early work
proposed that neutrophils pool physiologically in the
lungs such that up to 90% of the total blood neutrophil
pool resides within the pulmonary vasculature (Doers-
chuk et al. 1987). Following introduction of radiolabeled
neutrophils for imaging inflammation, however, it became
apparent that such a large pool was not compatible
with routine imaging findings (where pulmonary uptake
is minimal) and that the lung pulmonary pool only
becomes expanded in patients with severe systemic
inflammation, and then in proportion to the circulating
fraction of primed cells (Ussov et al. 1996). It has recently
been suggested that a prolonged pulmonary vascular tran-
sit time allows neutrophils to deprime before being
released back into the systemic circulation in an
unprimed state (Singh et al. 2012). Summers et al. (2009)
injected In-111-labeled neutrophils primed ex vivo with
GM-CSF and found 100% retention in the lungs followed
by a delayed release back into the circulation with a
40-min halftime.
We have had to make several assumptions, as follows.
(1) Colonic mucosal blood flow is 200 mL/min. This is
perhaps the most contentious assumption. However,
even assuming a blood flow of only 50 mL/min,
which seems unfeasibly low, the fraction of neutroph-
ils migrating would still be well under 20%.
(2) Mean neutrophil intravascular lifespan is 10 h, and not
reduced in inflammation. The relevant lifespan is that
of the labeled cells, which for In-111 has been dem-
onstrated not to be reduced in inflammatory disease
(Saverymuttu et al. 1985b).
(3) There is no difference between intravascular lifespans of
primed and unprimed neutrophils. Ex vivo, apoptosis
is delayed in primed neutrophils (Murray et al.
1997). However, in vivo, neutrophils disappear from
blood exponentially (Athens et al. 1961, 1965; Saver-
ymuttu et al. 1985b); that is they are destroyed at
random rather than any factor related to senescence.
In any event, if the lifespan of primed cells was pro-
longed, it can be seen from rearranging equation (2)
that we would have underestimated the spontaneous
depriming rate.
(4) All primed cells have the potential to deprime. This may
not be true depending on the priming stimulus. In
equation (3), t would therefore include values of infin-
ity for irreversibly primed cells, and the de-priming
rate of reversibly primed cells would therefore be
underestimated.
(5) After In-111-labeling, neutrophils retain the capacity to
migrate normally. This is very difficult to prove beyond
doubt. However, neutrophils labeled using optimal
separation techniques display a 40-min intravascular
recovery – 40–55% – (Ruparelia et al. 2011) close to
the maximum achievable on the basis of what we know
of normal neutrophil distribution between marginat-
ing and circulating pools (Athens et al. 1961, 1965;
Saverymuttu et al. 1985b).
(6) All neutrophils exiting a site of inflammation are primed.
This assumption could be validated by microsampling
of venular blood draining a site of inflammation, but
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to our knowledge this has not been done. If neutrophils
in a capillary axial stream escaped priming, it is possi-
ble that only 50% of incoming cells would become
primed. This would still result in a circulating Np per-
centage of 86%, much higher than the highest priming
percentages seen in severe IBD, which are about 40%.
(7) Transit time of primed neutrophils in the marginating
pool is not prolonged. If neutrophil transit time in the
marginated pool was prolonged then the total blood
neutrophil distribution volume would be greater. This
would impact on equations (1) and (3). Assuming
40% neutrophils were primed and that the transit time
in the marginated pool of primed neutrophils was
twice that of unprimed neutrophils, then the effective
volume of the marginated pool would be 7 L instead
of 5, giving a total effective volume of 12 L. From
equation (1), it can then be seen that the percentage of
neutrophils undergoing migration would be 5%
instead of 4%. In equation (3), there would be 40 units
of primed neutrophils in the marginating pool instead
of 20, giving a total of 60 units in the total blood neu-
trophil pool instead of 40. This would then give a
mean time to deprime of 58 min instead of 37 min.
In conclusion, we suggest first that 10% of neutroph-
ils delivered to a site of inflammation undergo migration,
leaving >90% to continue to circulate. Second, we further
suggest that these cells re-enter the circulation in a
primed state and thereafter undergo spontaneous in vivo
depriming with a halftime of about 40 min, a prediction
which fits well with in vitro experiments that examine the
rate of spontaneous depriming in vitro.
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